Laurus Labs Ltd - Share Price
LAURUSLABS
Laurus Labs LtdFinancials
Laurus Labs LtdNews & Updates
Rising Pharma in partnership with Laurus Labs to collaboration University of Minnesota
Mar 28,2020 12:17 PM
For a clinical trial exploring hydroxychloroquine as preventive treatment for COVID-19
Laurus Labs prepones dividend payment date Mar 26,2020
Laurus Labs prepones the date for paying dividend to its shareholders Mar 26,2020
Board of Laurus Labs recommends interim dividend Mar 13,2020
Laurus Labs fixes record date for interim dividend Mar 13,2020
Laurus Labs fixes record date for interim dividend Mar 12,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 1,280.25 | 51.47 | 17,572.25 | 94.75 | 0.48 | 2,529.50 | 266.78 |
| Dr Lal Pathlabs Ltd | 1,474.30 | 52.05 | 12,173.35 | 51.10 | 0.41 | 310.40 | 124.96 |
| Fortis Healthcare Ltd | 126.75 | 11.66 | 9,304.86 | 46.40 | 0.00 | 173.86 | 116.85 |
| Metropolis Healthcare Ltd | 1,354.80 | 52.84 | 6,682.98 | 32.30 | 1.00 | 172.91 | 91.60 |
| Narayana Hrudayalaya Ltd | 283.55 | 66.35 | 5,640.36 | 13.55 | 0.36 | 559.25 | 57.42 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Laurus Labs LtdSummary & Reports
Laurus Labs is a leading research and development (R&D) driven pharmaceutical company in India, with a leadership position in generic active pharmaceutical ingredients (APIs) for select, high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (P... More
Registered Office
Plot No 21 Jawaharlal Nehru,Pharma City Parawada,Visakhapatnam, Andhra Pradesh,531021
Tell. : +91-891-3061222
Website : http://www.lauruslabs.com
Email : secretarial@lauruslabs.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com
Reports by laurus-labs-ltd
Latest Release by laurus-labs-ltd
Result Express
Laurus Labs Ltd's Q3FY19 consolidated net profit declines 48.9% yoy to Rs17.82cr : Misses Estimates
Apr 09, 2020 05:03 PM
The company’s consolidated revenue stood at Rs529.46cr, up 10.55% yoy but down 10% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 32.04% |
| Total Promoter | 32.04% |
| Non Promoter | - |
| Institutions | 42.88% |
| Non-Institutions | 25.08% |
| Total Non-Promoter | 67.96% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
12 Mar 2020
Effective. Date
23 Mar 2020
Divi. Type
Interim
Divi.(%)
15
Divi. Amt.
1.5
Approved for the payment of interim dividend of Rs.1.50/- (15%) per equity share of Rs.10/- each, fo... More
Purpose
Board Meeting
Exp. Date
12 Mar 2020
Annc. Date
04 Mar 2020
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is schedul... More
Purpose
Board Meeting
Exp. Date
30 Jan 2020
Annc. Date
20 Jan 2020
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is schedul... More
